Expanded PBS listing for empagliflozin An RACGP expert describes the change as a ‘double win’, with the 1 April expansion to benefit more patients with type 2 diabetes.
Drug summit report reveals points for reform Building a better trained workforce is among its recommendations, with GPs calling for recognition of their ‘life-saving role’.
‘Alarming’: Study reveals kids’ chronic disease impact Research found 46% of Australian adolescents live with a chronic disease or developmental condition. What can GPs do to create change?
Sixty-day scripts slow to find favour: Study With a significantly lower-than-expected uptake, an RACGP expert says this could be caused by software impediments, complexity over medication eligibility, and patient views.
RSV infant immunisation programs now open across Australia As RSV case numbers grow, all states and territories have now launched programs to help protect infants against the infection.
‘Unprecedented’ update to antibiotic guidelines The first tranche of a major update from Therapeutic Guidelines has been released, with a focus on infections treated in primary care.
One in 15 Australian adults living with diabetes: ABS Around 6.6% of adults now have diabetes, up from 5.1% a decade earlier, according to new data.
Teens wait average of 100 days for mental health care: Study The Australian study found these lengthy wait times are exacerbating distress, but GPs say they are ‘hamstrung in providing care’.
Study suggests answer to reducing RSV hospital admissions Research evaluating the effectiveness of RSV vaccination among babies in WA has found a significant reduction in hospital admissions.
General practice pilot to ease ‘significant impacts’ of hay fever To boost low adherence to treatments, a new trial aims to support GPs through a tailored education toolkit used alongside daily nasal spray.